Dream potentiation can be described as a cognitive component which increases the intensity, vividness and frequency of sleeping dream states. This effect also results in dreams having a higher level of detail and definition alongside a greatly increased likelihood of them becoming lucid.
The experience of this effect can be the result of a class of drugs called oneirogens which is a class of hallucinogen that is used to specifically potentiate dreams when taken before sleep. However, it can also be an unintended residual effect from an extremely wide variety of substances or an effect that has arisen as a symptom of hallucinogen persisting perception disorder (HPPD).
Compounds which may cause this effect commonly include:
2-Fluorodeschloroketamine, 3-MeO-PCMo, 3-MeO-PCP, 4-MeO-PCP, 5-Hydroxytryptophan, 6-APB, 6-APDB, A-PVP, Acetylfentanyl, Alpha-GPC, Alprazolam, Aniracetam, Choline bitartrate, Citicoline, Clonazepam, Clonazolam, Codeine, Coluracetam, Datura, Deschloroetizolam, Deschloroketamine, DXM, Dextropropoxyphene, Diazepam, Diclazepam, Dihydrocodeine, Diphenhydramine, Diphenidine, Efavirenz, Ephenidine, Ethylmorphine, Etizolam, Fentanyl, Flubromazepam, Flubromazolam, Gabapentin, Haloperidol, Harmala alkaloid, Heroin, Hydrocodone, Hydromorphone, Ibogaine, Ketamine, Kratom, Lorazepam, MDA, MDEA, MDMA, Melatonin, Methadone, Methaqualone, MXE, Methoxphenidine, Metizolam, Mirtazapine, Morphine, Nifoxipam, O-Desmethyltramadol, Oxiracetam, Oxycodone, Oxymorphone, Pethidine, Phenylpiracetam, Piracetam, Pramiracetam, Pregabalin, Prochlorperazine, Pyrazolam, Quetiapine, Selective serotonin reuptake inhibitors, Tapentadol, Temazepam, Tramadol, U-47700, Zolpidem
Documentation written by Josie Kins